Search

Your search keyword '"Mezquita, Laura"' showing total 845 results

Search Constraints

Start Over You searched for: Author "Mezquita, Laura" Remove constraint Author: "Mezquita, Laura"
845 results on '"Mezquita, Laura"'

Search Results

7. Examination of the latent structure of the Ruminative Thoughts Style Questionnaire across countries, gender, and over time

9. Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non‐Small‐Cell Lung Cancer

10. Adverse childhood experiences and adulthood mental health: a cross-cultural examination among university students in seven countries

12. Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study

17. RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion

19. Validation of an abridged, 60-item form, of the Junior Spanish NEO inventory (JS NEO-A60)

20. Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer

23. Cross-Cultural Examination of the Community Reinforcement Approach Happiness Scale (CRA-HS): Testing measurement invariance in five countries

27. Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study

29. Clinical Utility and Outcomes Impact of Crystal Digital PCR of Sensitizing and Resistance EGFR Mutations in Patients With Advanced Non-Small Cell Lung Cancer

41. Cross-national examination of the Distress Tolerance Scale using Rasch methodology.

42. CD103+CD8+ TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17

44. Immune Checkpoint Inhibitors Rechallenge Efficacy in Non–Small-Cell Lung Cancer Patients

45. Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations

47. Circulating Tumor DNA Analysis for Patients with Oncogene-Addicted NSCLC With Isolated Central Nervous System Progression

50. Association between Lung Immune Prognostic Index and durvalumab consolidation outcomes in patients with locally advanced non-small cell lung cancer

Catalog

Books, media, physical & digital resources